Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Blarcamesine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 195615-83-9, Avex-73, Thd-dp-fm, Ae-37, Ae37, Blarcamesine [usan]
    Molecular Formula
    C19H23NO
    Molecular Weight
    281.4  g/mol
    InChI Key
    BOTHKNZTGGXFEQ-UHFFFAOYSA-N
    FDA UNII
    9T210MMZ3F
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    1-(2,2-diphenyloxolan-3-yl)-N,N-dimethylmethanamine
    2.1.2 InChI
    InChI=1S/C19H23NO/c1-20(2)15-18-13-14-21-19(18,16-9-5-3-6-10-16)17-11-7-4-8-12-17/h3-12,18H,13-15H2,1-2H3
    2.1.3 InChI Key
    BOTHKNZTGGXFEQ-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CN(C)CC1CCOC1(C2=CC=CC=C2)C3=CC=CC=C3
    2.2 Other Identifiers
    2.2.1 UNII
    9T210MMZ3F
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Anavex2-73

    2. Tetrahydro-n, N-dimethyl-2,2-diphenyl-3-furanmethanamine Hydrochloride

    2.3.2 Depositor-Supplied Synonyms

    1. 195615-83-9

    2. Avex-73

    3. Thd-dp-fm

    4. Ae-37

    5. Ae37

    6. Blarcamesine [usan]

    7. Anavex-2-73

    8. 9t210mmz3f

    9. Tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanemethanamine

    10. 1-(2,2-diphenyloxolan-3-yl)-n,n-dimethylmethanamine

    11. Blarcamesine (usan)

    12. Tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethanamine

    13. 3-furanmethanamine, Tetrahydro-n,n-dimethyl-2,2-diphenyl-

    14. 1-(2,2-diphenyltetrahydrofuran-3-yl)-n,n-dimethylmethanamine

    15. (r)-1-(2,2-diphenyltetrahydrofuran-3-yl)-n,n-dimethylmethanamine

    16. Unii-9t210mmz3f

    17. Anavex

    18. Ae 37

    19. Blarcamesine [inn]

    20. An2/avex-73

    21. Avex-73?

    22. Schembl181634

    23. Chembl4297224

    24. Gtpl11586

    25. Dtxsid60941344

    26. Bcp23552

    27. Ex-a3143

    28. Bdbm50559171

    29. Anavex-2-73 Free Base (blarcamesine)

    30. Db05592

    31. Sb17187

    32. Ncgc00387227-01

    33. Ac-35490

    34. Hy-105296

    35. Cs-0025655

    36. D11383

    37. D87137

    38. Q25110485

    39. Rac-1-((3r)-2,2-diphenyloxolan-3-yl)-n,n-dimethylmethanamine

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 281.4 g/mol
    Molecular Formula C19H23NO
    XLogP33.5
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count2
    Rotatable Bond Count4
    Exact Mass281.177964357 g/mol
    Monoisotopic Mass281.177964357 g/mol
    Topological Polar Surface Area12.5 Ų
    Heavy Atom Count21
    Formal Charge0
    Complexity298
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count1
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Investigated for use/treatment in breast cancer.